KANT

Tuhura Biosciences Completes Acquisition of Kineta

时间：2025-06-30 20:50:03 市场：美股综合

Kineta Announces Completion of Enrollment in the Monotherapy Arm of the Vista-101 Phase 1 Clinical Study in Advanced Solid Tumors

时间：2024-10-08 21:00:02 市场：美股综合

关联： KANT

Kineta Announces the Extension of the Tuhura Biosciences Exclusivity and Right of First Offer Agreement for Kva12123, Kineta’s Vista Blocking Antibody Currently in Phase 1

时间：2024-10-03 04:05:00 市场：综合美股

关联： KANT